KEPPRA
As listed in the register: KEPPRA
500 mg · tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Levetiracetam
- Made by
- Ucb Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Levetiracetam). It describes the substance, not this exact product.
The precise mechanism(s) by which levetiracetam exerts its antiepileptic effect is unknown.
A saturable and stereoselective neuronal binding site in rat brain tissue has been described for levetiracetam.
Levetiracetam is not extensively metabolized in humans.
Levetiracetam is eliminated from the systemic circulation by renal excretion as unchanged drug which represents 66% of administered dose.
Food does not affect the extent of absorption of levetiracetam but it decreases C max by 20% and delays T max by 1.5 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-04
Safety of the active substance
From the US prescribing label for the same active substance (Levetiracetam). It describes the substance, not this exact product.
- Levetiracetam tablets are contraindicated in patients with a hypersensitivity to levetiracetam.
- Reactions have included anaphylaxis and angioedema [see Warnings and Precautions (5.4) ].
- Known hypersensitivity to levetiracetam; angioedema and anaphylaxis have occurred ( 4, 5.4 )
Most common adverse reactions (incidence ≥ 5% more than placebo) include:.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States64 matching products
- Levetiracetam 500 mg · Tablet, Film Coated55 makers
- Levetiracetam Er 500 mg · Tablet, Film Coated, Extended Release3 makers
- Levetiracetam Extended-Release 500 mg · Tablet, Film Coated, Extended Release3 makers
- Keppra 500 mg · Tablet, Film Coated
- Keppra Xr 500 mg · Tablet, Film Coated, Extended Release
- Spritam 500 mg · Tablet, for Suspension
European UnionNo exact match for this strength and form
Spain38 matching products
- KEPPRA 500mg · comprimido recubierto con película4 makers
- EVEXIBAM 500 mg · comprimido recubierto con película
- LAURAK 500 mg / COMPRIMIDO · comprimido recubierto con película
- LEVETIRACETAM ACCORD 500 mg levetiracetam · comprimido recubierto con película
- LEVETIRACETAM ACTAVIS 500 mg levetiracetam · comprimido recubierto con película
- LEVETIRACETAM ALMUS 500 mg · comprimido recubierto con película
- LEVETIRACETAM ALTER 500 mg · comprimido recubierto con película
- LEVETIRACETAM ARISTO 500 mg · comprimido recubierto con película
Netherlands18 matching products
- DRETACEN 500 mg 500 mg · filmomhulde tablet
- Keppra 500 mg filmomhulde tabletten 500 mg · filmomhulde tablet
- Levetiracetam 1 A Pharma 500 mg 500 mg · filmomhulde tablet
- Levetiracetam Accord 500 mg 500 mg · filmomhulde tablet
- Levetiracetam Actavis 500 mg 500 mg · filmomhulde tablet
- Levetiracetam Amarox 500 mg 500 mg · filmomhulde tablet
- Levetiracetam AMETAS 500 mg 500 mg · filmomhulde tablet
- Levetiracetam Aristo 500 mg 500 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Ucb Canada Inc |
|---|---|
| Active substance | Levetiracetam |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 500 mg |
| Form | tablet |
| Classification | N03AX14 · Pain, sleep, mood, epilepsy and the brain |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02247028 |
| DPD drug code | 71263 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.